Clinical and genetic characteristics of 165 children with salt-wasting 21-hydroxylase deficiency in Henan Province

Hai-Hua YANG, Ai HUANG, Yuan LI, Yong-Xing CHEN, Hai-Yan WEI

Chinese Journal of Contemporary Pediatrics ›› 2026, Vol. 28 ›› Issue (4) : 480-485.

PDF(527 KB)
HTML
PDF(527 KB)
HTML
Chinese Journal of Contemporary Pediatrics ›› 2026, Vol. 28 ›› Issue (4) : 480-485. DOI: 10.7499/j.issn.1008-8830.2506116
CLINICAL RESEARCH

Clinical and genetic characteristics of 165 children with salt-wasting 21-hydroxylase deficiency in Henan Province

Author information +
History +

Abstract

Objective To explore the clinical and genetic characteristics of children with salt-wasting (SW) 21-hydroxylase deficiency (21-OHD) in Henan Province. Methods Clinical characteristics, laboratory results, and genetic findings were retrospectively reviewed for 165 children with SW 21-OHD who presented to the Department of Endocrinology and Genetic Metabolism, Children's Hospital Affiliated to Zhengzhou University, from August 2007 to November 2023. Associations between clinical characteristics and genotypes were analyzed. Results Of the 165 patients, 100 were biologically male and 65 female. The median age at diagnosis was 40 days in males and 28 days in females. Skin and mucosal hyperpigmentation occurred in 155 patients (93.9%), vomiting in 151 patients (91.5%), and failure to gain weight in 153 patients (92.7%). All females had clitoral hypertrophy. At presentation, 161 (97.6%) had adrenal crisis. Hyperkalemia (serum potassium >5.5 mmol/L) was present in 83.0% (137/165), and hyponatremia (serum sodium <135 mmol/L) in 93.9% (155/165). Elevated adrenocorticotropic hormone (ACTH) occurred in 96.4% (159/165), decreased cortisol in 90.3% (149/165), and elevated testosterone and 17-hydroxyprogesterone (17-OHP) in 100% (165/165). Six patients with male social gender had a 46,XX karyotype. All patients carried homozygous or compound heterozygous pathogenic variants in CYP21A2; 330 variants representing 29 types were identified, with c.293-13A/C>G (37.3%) and large deletions (22.4%) being most common. Twenty patients carried recombinant alleles between CYP21A2 and CYP21A1P. Across genotype groups, serum potassium, sodium, ACTH, testosterone, and cortisol showed no statistically significant differences (P>0.05), whereas 17-OHP levels differed significantly (P<0.05). Conclusions SW 21-OHD typically presents with adrenal crisis. Hyperkalemia, hyponatremia, elevated 17-OHP, testosterone, and ACTH, together with decreased cortisol, support the diagnosis; definitive confirmation requires genetic testing. Genotype does not fully predict clinical phenotype.

Key words

21-Hydroxylase deficiency / Salt-wasting / CYP21A2 / Child

Cite this article

Download Citations
Hai-Hua YANG , Ai HUANG , Yuan LI , et al . Clinical and genetic characteristics of 165 children with salt-wasting 21-hydroxylase deficiency in Henan Province[J]. Chinese Journal of Contemporary Pediatrics. 2026, 28(4): 480-485 https://doi.org/10.7499/j.issn.1008-8830.2506116

References

[1]
Speiser PW, Arlt W, Auchus RJ, et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline[J]. J Clin Endocrinol Metab, 2018, 103(11): 4043-4088. PMCID: PMC6456929. DOI: 10.1210/jc.2018-01865 .
[2]
Speiser PW, Azziz R, Baskin LS, et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline[J]. J Clin Endocrinol Metab, 2010, 95(9): 4133-4160. PMCID: PMC2936060. DOI: 10.1210/jc.2009-2631 .
[3]
Espinosa Reyes TM, Collazo Mesa T, Lantigua Cruz PA, et al. Genotype-phenotype correlation in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Cuba[J]. Int J Endocrinol, 2021, 2021: 9316284. PMCID: PMC7806372. DOI: 10.1155/2021/9316284 .
[4]
Xia Y, Shi P, Gao S, et al. Genetic analysis and novel variation identification in Chinese patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency[J]. J Steroid Biochem Mol Biol, 2022, 222: 106156. DOI: 10.1016/j.jsbmb.2022.106156 .
[5]
Wang X, Wang Y, Ma D, et al. Neonatal screening and genotype-phenotype correlation of 21-hydroxylase deficiency in the Chinese population[J]. Front Genet, 2020, 11: 623125. PMCID: PMC7862715. DOI: 10.3389/fgene.2020.623125 .
[6]
Nowotny H, Ahmed SF, Bensing S, et al. Therapy options for adrenal insufficiency and recommendations for the management of adrenal crisis[J]. Endocrine, 2021, 71(3): 586-594. PMCID: PMC7929907. DOI: 10.1007/s12020-021-02649-6 .
[7]
中国高血压防治指南修订委员会, 高血压联盟(中国, 中华医学会心血管病学分会, 等. 中国高血压防治指南(2018年修订版)[J]. 中国心血管杂志, 2019, 24(1): 24-56. DOI: 10.3969/j.issn.1007-5410.2019.01.002 .
[8]
Concolino P, Costella A. Congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency: a comprehensive focus on 233 pathogenic variants of CYP21A2 gene[J]. Mol Diagn Ther, 2018, 22(3): 261-280. DOI: 10.1007/s40291-018-0319-y .
[9]
Wedell A, Thilén A, Ritzén EM, et al. Mutational spectrum of the steroid 21-hydroxylase gene in Sweden: implications for genetic diagnosis and association with disease manifestation[J]. J Clin Endocrinol Metab, 1994, 78(5): 1145-1152. DOI: 10.1210/jcem.78.5.8175971 .
[10]
Speiser PW, Dupont J, Zhu D, et al. Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency[J]. J Clin Invest, 1992, 90(2): 584-595. PMCID: PMC443137. DOI: 10.1172/JCI115897 .
[11]
Kliegman R, Geme JWS III. Nelson Textbook of Pediatrics[M]. 21st ed. Amsterdam: Elsevier, 2019.
[12]
Shima R, Sawano K, Shibata N, et al. Timing of hyponatremia development in patients with salt-wasting-type 21-hydroxylase deficiency[J]. Clin Pediatr Endocrinol, 2020, 29(3): 105-110. PMCID: PMC7348630. DOI: 10.1297/cpe.29.105 .
[13]
张令晖, 胡菊萍, 胡蜀红, 等. 失盐型类固醇21-羟化酶缺乏症64例临床分析[J]. 华中科技大学学报(医学版), 2015(6): 714-717. DOI: 10.3870/j.issn.1672-0741.2015.06.020 .
[14]
中华医学会儿科学分会内分泌遗传代谢病学组. 先天性肾上腺皮质增生症21-羟化酶缺陷诊治共识[J]. 中华儿科杂志, 2016, 54(8): 569-576. DOI: 10.3760/cma.j.issn.0578-1310.2016.08.003 .
[15]
Xu Z, Chen W, Merke DP, et al. Comprehensive mutation analysis of the CYP21A2 gene: an efficient multistep approach to the molecular diagnosis of congenital adrenal hyperplasia[J]. J Mol Diagn, 2013, 15(6): 745-753. PMCID: PMC5803549. DOI: 10.1016/j.jmoldx.2013.06.001 .
[16]
Dumic KK, Grubic Z, Yuen T, et al. Molecular genetic analysis in 93 patients and 193 family members with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Croatia[J]. J Steroid Biochem Mol Biol, 2017, 165(Pt A): 51-56. DOI: 10.1016/j.jsbmb.2016.03.035 .
[17]
New MI, Abraham M, Gonzalez B, et al. Genotype-phenotype correlation in 1,507 families with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency[J]. Proc Natl Acad Sci U S A, 2013, 110(7): 2611-2616. PMCID: PMC3574953. DOI: 10.1073/pnas.1300057110 .
[18]
Dolzan V, Sólyom J, Fekete G, et al. Mutational spectrum of steroid 21-hydroxylase and the genotype-phenotype association in Middle European patients with congenital adrenal hyperplasia[J]. Eur J Endocrinol, 2005, 153(1): 99-106. DOI: 10.1530/eje.1.01944 .
[19]
Anastasovska V, Kocova M. Genotype-phenotype correlation in CAH patients with severe CYP21A2 point mutations in the Republic of Macedonia[J]. J Pediatr Endocrinol Metab, 2010, 23(9): 921-926. DOI: 10.1515/jpem.2010.147 .
[20]
Riedl S, Röhl FW, Bonfig W, et al. Genotype/phenotype correlations in 538 congenital adrenal hyperplasia patients from Germany and Austria: discordances in milder genotypes and in screened versus prescreening patients[J]. Endocr Connect, 2019, 8(2): 86-94. PMCID: PMC6365666. DOI: 10.1530/EC-18-0281 .
[21]
Tsuji A, Konishi K, Hasegawa S, et al. Newborn screening for congenital adrenal hyperplasia in Tokyo, Japan from 1989 to 2013: a retrospective population-based study[J]. BMC Pediatr, 2015, 15: 209. PMCID: PMC4681082. DOI: 10.1186/s12887-015-0529-y .
[22]
Krone N, Arlt W. Genetics of congenital adrenal hyperplasia[J]. Best Pract Res Clin Endocrinol Metab, 2009, 23(2): 181-192. PMCID: PMC5576025. DOI: 10.1016/j.beem.2008.10.014 .
[23]
Su L, Yin X, Cheng J, et al. Clinical presentation and mutational spectrum in a series of 166 patients with classical 21-hydroxylase deficiency from South China[J]. Clin Chim Acta, 2018, 486: 142-150. DOI: 10.1016/j.cca.2018.07.039 .
[24]
Hong G, Park HD, Choi R, et al. CYP21A2 mutation analysis in Korean patients with congenital adrenal hyperplasia using complementary methods: sequencing after long-range PCR and restriction fragment length polymorphism analysis with multiple ligation-dependent probe amplification assay[J]. Ann Lab Med, 2015, 35(5): 535-539. PMCID: PMC4510508. DOI: 10.3343/alm.2015.35.5.535 .

Footnotes

所有作者均声明无利益冲突。

PDF(527 KB)
HTML

Accesses

Citation

Detail

Sections
Recommended

/